Indications
Treatment of cervical cancer
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Raligize
- ATC code
- L01X
- Therapeutic area
- Uterine Cervical Neoplasms
- Marketing authorisation holder
- FGK Representative Service GmbH
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/004473
EMA designations
- Orphan medicine
- No
- Conditional approval
- No
- Biosimilar
- No